Imaging and Focal Therapy of Early Prostate Cancer

 
 
Springer (Verlag)
  • 2. Auflage
  • |
  • erschienen am 7. August 2018
 
  • Buch
  • |
  • Softcover
  • |
  • XX, 483 Seiten
978-3-319-84271-4 (ISBN)
 

This text encompass an up-to-date, comprehensive review of the state-of-the-art for gland preserving therapies. Fully updated and revised, this text evaluates the scientific evidence for the evolving trend to treat intermediate risk, clinically localized prostate cancer in a focally ablative manner with novel gland-preserving, focal therapy methods. Various ablative devices such as high intensity focused ultrasound, irreversible electroporation, photodynamic therapy, cryotherapy and laser ablation, among others, is discussed in regard to their strengths and limitations as a therapeutic modality. Emphasis is placed on patient selection and outcomes utilizing both advanced imaging techniques and pathologic evaluation.

Current and new approaches to image cancer foci within the prostate (multiparametric ultrasonography, multiparametric magnetic resonance image, etc) are presented along with various biopsy techniques, including robotics to map prostate cancer. Patient selection based on imaging and genomic classification, adjuvants to enhance therapy, treatment strategy, outcomes and patient centered concerns is discussed, providing an acceptable balance between cancer control and improved quality of life for patients.

Written by experts in the field and lavishly illustrated with detailed line-art and photographs, Imaging and Focal Therapy of Early Prostate Cancer, Second Edition is designed as a comprehensive resource for urologists, radiation oncologists, medical oncologists, radiologists, uropathologists, molecular biologists, biomedical engineers, other clinicians -- residents, fellows, nurses and allied professionals -- and researchers with an interest in the diagnosis and novel treatment of prostate cancer. It will provide insight into the latest research and clinical applications of image-guided diagnosis and minimally invasive focal, gland-preserving treatment for prostate cancer.

Softcover reprint of the original 2nd ed. 2017
  • Englisch
  • Cham
  • |
  • Schweiz
Springer International Publishing
  • Für Beruf und Forschung
  • Überarbeitete Ausgabe
  • 118
  • |
  • 97 farbige Abbildungen, 36 s/w Abbildungen, 118 farbige Tabellen
  • |
  • 118 Tables, color; 97 Illustrations, color; 36 Illustrations, black and white; XX, 483 p. 133 illus., 97 illus. in color.
  • Höhe: 25.4 cm
  • |
  • Breite: 17.8 cm
  • 1286 gr
978-3-319-84271-4 (9783319842714)
10.1007/978-3-319-49911-6
weitere Ausgaben werden ermittelt
Thomas J. Polascik, MD, FACSDivision of Urology, Department of SurgeryDuke Cancer InstituteDuke University School of MedicineDurham, North Carolina, USA
Table of ContentsImaging and Focal Therapy of Early Prostate Cancer, 2EEditor: Thomas J. Polascik Foreword Jean J. M. C. H. de la Rosette Preface Acknowledgments Contributors Section 1: Why Focal Therapy? Chapter 1. Evolution in the Concept of Focal Therapy: the Story of Breast Cancer and Prostate Cancer Isabel García-Fleury, Chi-hang Yee, Marco Antonio López-Tovar, Adriana Pesci-Feltri, Arjun Sivaraman, and Rafael Sanchez-Salas Chapter 2 Targeted Therapy for Localized Kidney Cancer Zhamshid Okhunov, Roshan M. Patel, and Jaime Landman Chapter 3. Focal Therapy for Prostate Cancer: A Guide for Patients Kae Jack Tay and Thomas J. Polascik Section 2: Global Perspective of Active Surveillance and Focal Therapy Chapter 4. Low-Risk Prostate Cancer in North America: Rationale, Uptake, and Limitations of Active Surveillance and Opportunities for Focal Therapy Raj Satkunasivam and Laurence Klotz Chapter 5. Focal Therapy and Active Surveillance in Europe Jan Philipp Radtke, Angelo Territo, Markus R. Hohenfellner, and Alberto Breda Chapter 6. Focal Therapy and Active Surveillance of Prostate Cancer in East and Southeast Asia Masaki Kimura, Kae Jack Tay, Satoru Muto, and Shigeo Horie Section 3: Scientific Foundation for the Focal Therapy Concept Chapter 7. Pathologic Rationale for Focal Therapy of Prostate Cancer: Elucidating Tumor Characteristics and Biology Vladimir Mouraviev, Arnauld Villers , Thomas M. Wheeler, Rodolfo Montironi, Pierre Nevoux, Ariel Schulman, and Thomas J. Polascik Chapter 8. Identifying and Characterizing the Index Lesion Lina M. Carmona Echeverria, Hayley Whitaker, and Hashim U. Ahmed Chapter 9. Utilizing Biopsy-Based Genomic Assays to Risk-Stratify Patients Robert Qi, Stephen J. Freedland, and Judd W. Moul Chapter 10. Patient Selection for Focal Therapy of Prostate Cancer Arjun Sivaraman and Rafael Sanchez-Salas Chapter 11. Prostate Focal Therapy: Definitions and Common Terminology John F. Ward Section 4: Multiparametric MRI and ARFI Imaging of the Prostate Chapter 12. Reading and Reporting Standards: The Prostate Imaging Reporting And Data System - What Is It and What Can It Do? Wulphert Venderink and Jurgen J. Fütterer Chapter 13. Role of Magnetic Resonance Imaging in Prostate Cancer Assessment Sonia Gaur, Sherif Mehralivand, Baris Turkbey, and Peter L. Choyke Chapter 14. Optimizing Multiparametric Magnetic Resonance Imaging for a Focal Therapy Practice: Quality Improvement Jamie N. Holtz and Rajan T. Gupta Chapter 15. Acoustic Radiation Force Impulse Imaging for Targeting: Correlation with Histology Mark L. Palmeri and Kathryn R. Nightingale Section 5: Prostate Biopsy Techniques Chapter 16. In-Bore Magnetic Resonance Imaging-Targeted Biopsy Igor Trilisky, Aytekin Oto, and Scott Eggener Chapter 17. Multiparametric MRI-TRUS Fusion Biopsy, Outcomes, and Commercial Systems Akhil Muthigi, Ardeshir R. Rastinehad, Arvin K. George, Masakatsu Oishi, Osamu Ukimura, and Peter A. Pinto Chapter 18. Detecting, Localizing, and Treating the Multiparametric Magnetic Resonance Imaging Invisible Lesion: Utilizing Three-Dimensional Transperineal Mapping Nelson N. Stone and E. David Crawford Chapter 19. Multiparametric Transrectal Ultrasound Biopsy Arnoud W. Postema, Jochen Walz, and Hessel Wijkstra Chapter 20. Robotic Magnetic Resonance Imaging Targeting for Biopsy and Therapy Wesley W. Ludwig, Mohamad E. Allaf, and Dan Stoianovici Section 6: Technologies for Focal Therapy: Transperineal Approach Chapter 21. In-Bore Transperineal Magnetic Resonance Imaging-Guided Laser Ablation Nathan Perlis, John Trachtenberg, and Sangeet Ghai Chapter 22. Focal Cryoablation Kae Jack Tay, Efrat Tsivian, and Thomas J. Polascik Chapter 23. Photodynamic Therapy for Early Prostate Cancer Caroline M. Moore and Mark Emberton Section 7: Technologies for Focal Therapy: Transrectal Approach Chapter 24 High-Intensity Focused Ultrasound Paolo Capogrosso and Eric Barret Chapter 25. Transrectal Laser Focal Therapy of Prostate Cancer John F. Feller, Bernadette M. Greenwood, and R. Jason Stafford Section 8: New Approaches and Applications of Focal Therapy Chapter 26. Focal Therapy for Prostate Cancer: a Molecular Biology Approach with TRAIL Vikram Narayan, Badrinath R. Konety, and Thomas S. Griffith Chapter 27. Focal Brachytherapy and Intensity Modulated Radiation Therapy R. Alex Hsi Chapter 28. Focal Therapy for Anterior Cancers (Originated from Transition Zone) Arnauld Villers and Kae Jack Tae Section 9: Manipulating the Microenvironment for Optimization Chapter 29. The Story of Adjuvants to Boost the Performance of Cryoablation Kimberly L. Santucci, John M. Baust, Kristi K. Snyder, Anthony Robilotto, Robert G. VanBuskirk, and John G. Baust Chapter 30. 5-Alpha-Reductase Inhibition as a Secondary Preventive Strategy Nathan Perlis and Antonio Finelli Section 10: Determining Outcomes of Focal Therapy Chapter 31. Measuring Patient-Based Outcomes: Setting Realistic Expectations When Balancing Functional Outcomes with Cancer Control Behfar Ehdaie and Arjun Sivaraman Chapter 32. Pathologic Assessment and Implications Following Focal Therapy of Prostate Cancer Rafael E. Jimenez, Andrew Evans, James Kench, Rodolfo Montironi, and Mahul B. Amin Chapter 33. Post-Treatment Surveillance Using Multiparametric Magnetic Resonance Imaging Alex Kirkham Chapter 34. Determining Focal Therapy Failure and Salvage Options Theo M. de Reijke, Arnoud W. Postema, and J. Stephen Jones Chapter 35. Positioning Focal Therapy from Consensus to Guidelines Matthijs J. V. Scheltema, Anouk E. Hentschel, and Jean J. M. C. H. de la Rosette
This text encompass an up-to-date, comprehensive review of the state-of-the-art for gland preserving therapies. Fully updated and revised, this text evaluates the scientific evidence for the evolving trend to treat intermediate risk, clinically localized prostate cancer in a focally ablative manner with novel gland-preserving, focal therapy methods. Various ablative devices such as high intensity focused ultrasound, irreversible electroporation, photodynamic therapy, cryotherapy and laser ablation, among others, is discussed in regard to their strengths and limitations as a therapeutic modality. Emphasis is placed on patient selection and outcomes utilizing both advanced imaging techniques and pathologic evaluation.
Current and new approaches to image cancer foci within the prostate (multiparametric ultrasonography, multiparametric magnetic resonance image, etc) are presented along with various biopsy techniques, including robotics to map prostate cancer. Patient selection based on imaging and genomic classification, adjuvants to enhance therapy, treatment strategy, outcomes and patient centered concerns is discussed, providing an acceptable balance between cancer control and improved quality of life for patients.


Written by experts in the field and lavishly illustrated with detailed line-art and photographs, Imaging and Focal Therapy of Early Prostate Cancer, Second Edition is designed as a comprehensive resource for urologists, radiation oncologists, medical oncologists, radiologists, uropathologists, molecular biologists, biomedical engineers, other clinicians -- residents, fellows, nurses and allied professionals -- and researchers with an interest in the diagnosis and novel treatment of prostate cancer. It will provide insight into the latest research and clinical applications of image-guided diagnosis and minimally invasive focal, gland-preserving treatment for prostate cancer.
DNB DDC Sachgruppen

Versand in 10-15 Tagen

139,09 €
inkl. 7% MwSt.
in den Warenkorb